medicine. this is the first covid pill. trial results suggest it can cut hospitalisations or deaths by half. the news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo or dummy pill later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful.
hospitalisations or deaths by half. the news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated, elderly or medically at risk volunteers within five days of them showing coronaviruses symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who didn t take the tablets. eight patients who were given a placebo or dummy pill later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. but data still needs to be peer reviewed.
the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 1a.1% of those who didn t take the tablets. eight patients who were given a placebo or dummy pill later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. but data still needs to be peer reviewed. so how does it work? as coronavirus replicates itself inside your body, these antiviral pills trick it into using the drug, which then inserts errors into the virus s genetic code, blocking the virus from replicating. it completely corrupts the genome of the virus so it can t replicate, and that s the beauty. and then, even if the virus mutates, it could be still useful. people are now talking about this, that if we have another coronavirus pandemic in the future,
that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated, elderly or medically at risk volunteers within five days of them showing coronaviruses symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who didn t take the tablets. eight patients who were given a placebo or dummy pill later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. but data still needs to be peer reviewed. so how does it work? as coronavirus replicates itself inside your body, these antiviral pills trick it into using the drug, which then inserts errors into the virus s genetic code, blocking the virus from replicating.
unvaccinated, elderly or medically at risk volunteers within five days of them showing coronaviruses symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 1a.1% of those who didn t take the tablets. eight patients who were given a placebo or dummy pill later died of covid, but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. but data still needs to be peer reviewed. so how does it work? as coronavirus replicates itself inside your body, these antiviral pills trick it into using the drug, which then inserts errors into the virus s genetic code, blocking the virus from replicating. it completely corrupts the genome of the virus so it can t replicate, and that s the beauty. and then, even if the virus mutates,